201 related articles for article (PubMed ID: 18199996)
1. Drug insight: translating evidence on statin therapy into clinical benefits.
Sanossian N; Ovbiagele B
Nat Clin Pract Neurol; 2008 Jan; 4(1):43-9. PubMed ID: 18199996
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy and stroke prevention: what was known, what is new and what is next?
Mazighi M; Lavallée PC; Labreuche J; Amarenco P
Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
Chaturvedi S; Zivin J; Breazna A; Amarenco P; Callahan A; Goldstein LB; Hennerici M; Sillesen H; Rudolph A; Welch MA;
Neurology; 2009 Feb; 72(8):688-94. PubMed ID: 18768917
[TBL] [Abstract][Full Text] [Related]
4. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
Schwertz DW; Badellino KO
J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
[TBL] [Abstract][Full Text] [Related]
5. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
Stalenhoef AF
Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
[TBL] [Abstract][Full Text] [Related]
6. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study.
van den Bogaard B; van den Born BJ; Fayyad R; Waters DD; DeMicco DA; LaRosa JC; Kastelein JJ; Holme I;
Eur J Clin Invest; 2011 Feb; 41(2):134-42. PubMed ID: 20868450
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
Wiviott SD; Cannon CP
Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
[TBL] [Abstract][Full Text] [Related]
8. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
[TBL] [Abstract][Full Text] [Related]
9. Statins and stroke prevention.
Paciaroni M; Bogousslavsky J
Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
[TBL] [Abstract][Full Text] [Related]
10. Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?
Sanossian N; Saver JL; Liebeskind DS; Kim D; Razinia T; Ovbiagele B
Arch Neurol; 2006 Aug; 63(8):1081-3. PubMed ID: 16908732
[TBL] [Abstract][Full Text] [Related]
11. Statins and stroke prevention.
Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
[TBL] [Abstract][Full Text] [Related]
12. [Statins in stroke prevention].
Gedikli O; Baykan M
Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
14. Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack.
Chen PS; Cheng CL; Kao Yang YH; Yeh PS; Li YH
Acta Neurol Scand; 2014 Jan; 129(1):41-8. PubMed ID: 23758549
[TBL] [Abstract][Full Text] [Related]
15. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.
Greisenegger S; Müllner M; Tentschert S; Lang W; Lalouschek W
J Neurol Sci; 2004 Jun; 221(1-2):5-10. PubMed ID: 15178206
[TBL] [Abstract][Full Text] [Related]
16. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
17. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Schwartz GG; Chaitman BR; Goldberger JJ; Messig M
Am Heart J; 2011 May; 161(5):993-9. PubMed ID: 21570534
[TBL] [Abstract][Full Text] [Related]
18. [After TIA and stroke: a statin for secondary prevention?].
MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
[No Abstract] [Full Text] [Related]
19. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
20. [Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].
Castilla-Guerra L; Fernández-Moreno Mdel C; López-Chozas JM
Clin Investig Arterioscler; 2016; 28(4):202-8. PubMed ID: 26150172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
